US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 21.080
- +0.270+1.30%
Trading Aug 19 09:30 ET
771.03MMarket Cap-12234P/E (TTM)
21.080High21.080Low426Volume21.060Open20.810Pre Close8.98KTurnover0.01%Turnover RatioLossP/E (Static)36.58MShares28.08052wk High2.29P/B193.94MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float28.080Historical High--Div YieldTTM0.00%Amplitude16.550Historical Low21.080Avg Price1Lot Size
Rapport Therapeutics News
TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics Analyst Ratings
Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
